Novo Nordisk execs sell out after receiving shares

Several people at the top of Novo Nordisk have sold shares that they had just received as a part of a long-term incentive program.

Photo: Jacob Gronholt-Pedersen/REUTERS / X04292

People at the top of Novo Nordisk have sold company shares, as reported in a notification on Friday. This comes after the majority of the company’s leadership received shares in connection with a long-term incentive program at Novo Nordisk.

On February 3, CFO Karsten Munk Knudsen received 21,551 shares under the incentive program, of which he sold 10,000 shares the day after, totaling DKK 6.7m (USD 1m) at market value.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Britt Meelby Jensen wants to rebuild trust in Ambu

After a turbulent time for Ambu under Juan Jose Gonzalez’s reign, new chief executive appointee Britt Meelby Jensen aims to rebuild the trust in the medtech firm, which has downgraded its expectations seven times over the past three years.

Outgoing Ambu CEO commends colleagues

”A true privilege,” says Juan Jose Gonzalez, describing his time as CEO at Ambu, which came to an end with Thursday’s announcement that Britt Meelby Jensen would take over the role.

Further reading

Related articles

Latest news

See all jobs